Daiichi Sankyo and Waiv partner for ADC biomarkers
The platform will be applied to identify potential biomarkers linked to treatment response prior to upcoming trial phases.
Drug Development
Halozyme and Oruka sign agreement for Hypercon technology
Citius raises $36.5m for Lymphir commercialisation
MSD concludes Terns acquisition to expand CML pipeline
Lannett, Lanexa Biologics and Sunshine Lake secure FDA approval for Langlara
Latus Bio secures $97m in funding to boost gene therapy access
Arrowhead’s Redemplo secures Australian TGA approval for FCS therapy
Novo Nordisk to launch Ozempic for type 2 diabetes in US
